Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-

-

 
WKN: A3DR6K / Symbol: ATHX / Name: Athersys / Stock / Biotechnology & Medical Research / Small Cap /
Your prediction

Athersys Inc. Stock

Our community identified positive and negative aspects for Athersys Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Athersys Inc. stock. On the other hand our users think that "Unique positioning" could be a problem in the future.

Pros and Cons of Athersys Inc. in the next few years

Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Athersys Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Athersys Inc. - - - - - - -
Ardelyx Inc. 0.910% -2.116% -15.296% 40.514% 4.048% -12.204% -
Salarius Pharmaceuticals Inc. -3.170% 2.315% -15.000% -67.971% -20.360% -98.187% -99.994%
Brainstorm Cell 1.170% -1.874% -1.485% -81.975% 114.440% -80.717% -

Comments

Athersys, Inc. (NASDAQ: ATHX) is now covered by analysts at Alliance Global Partners. They set a "buy" rating on the stock.
Ratings data for ATHX provided by MarketBeat
Show more